180 related articles for article (PubMed ID: 15090969)
1. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin.
Collin M; Patel NS; Dugo L; Thiemermann C
Crit Care Med; 2004 Mar; 32(3):826-31. PubMed ID: 15090969
[TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.
Abdelrahman M; Collin M; Thiemermann C
Shock; 2004 Dec; 22(6):555-61. PubMed ID: 15545828
[TBL] [Abstract][Full Text] [Related]
3. 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria.
Dugo L; Collin M; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Sep; 498(1-3):295-301. PubMed ID: 15364008
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
5. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia.
Collin M; Murch O; Thiemermann C
Crit Care Med; 2006 Apr; 34(4):1131-8. PubMed ID: 16484917
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
8. The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.
Marzocco S; Di Paola R; Mazzon E; Genovese T; Britti D; Pinto A; Autore G; Cuzzocrea S
Intensive Care Med; 2005 May; 31(5):693-700. PubMed ID: 15868139
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
10. 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ ameliorates endotoxin-induced acute lung injury in rats.
Liu D; Geng Z; Zhu W; Wang H; Chen Y; Liang J
Chin Med J (Engl); 2014; 127(5):815-20. PubMed ID: 24571868
[TBL] [Abstract][Full Text] [Related]
11. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
12. The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock.
Collin M; Thiemermann C
Eur J Pharmacol; 2003 Aug; 476(3):257-8. PubMed ID: 12969773
[TBL] [Abstract][Full Text] [Related]
13. Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia.
Hauser B; Kick J; Iványi Z; Asfar P; Ehrmann U; Muth CM; Albicini M; Wachter U; Vogt J; Bauer M; Brückner UB; Radermacher P; Bracht H
Intensive Care Med; 2006 May; 32(5):759-65. PubMed ID: 16534570
[TBL] [Abstract][Full Text] [Related]
14. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala EM; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2005 Sep; 33(9):1903-12. PubMed ID: 16148458
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
Liu D; Zeng BX; Zhang SH; Wang YL; Zeng L; Geng ZL; Zhang SF
Crit Care Med; 2005 Oct; 33(10):2309-16. PubMed ID: 16215386
[TBL] [Abstract][Full Text] [Related]
16. Effect of 15-Deoxy-△(12,14)-prostaglandin J2 on Expression of Macrophage Migration Inhibitory Factor in Mouse Monocyte/macrophage Cell Line J774A.1.
Li WY; Shi YM; Liu X; Yang L; L I LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):247-52. PubMed ID: 27544994
[TBL] [Abstract][Full Text] [Related]
17. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
Bernardo A; Levi G; Minghetti L
Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J
J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850
[TBL] [Abstract][Full Text] [Related]
20. Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.
Dugo L; Collin M; Allen DA; Murch O; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2006 May; 34(5):1489-96. PubMed ID: 16557150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
